论文部分内容阅读
目的:研究逐瘀活血汤联合尿激酶治疗糖尿病玻璃体积血的临床疗效。方法:将我院2013年2月至2014年2月70例糖尿病玻璃体积血患者抽签随机分为观察组与对照组,均为35例,观察组采取逐瘀活血汤与尿激酶联合治疗,对照组使用尿激酶治疗,比较两组疗效。结果:使用逐瘀活血汤联合尿激酶治疗的观察组的总有效率为91.43%明显高于采用单一尿激酶治疗的对照组的65.71%,两组差异有统计学意义(P<0.05)。结论:逐瘀活血汤联合尿激酶治疗糖尿病玻璃体积血具有众多优势,针对发病病因一一解决,有较强的临床应用价值。
Objective: To study the clinical efficacy of Zhuyu Huoxue Decoction combined with urokinase in the treatment of diabetic vitreous hemorrhage. Methods: 70 patients with diabetic vitreous hemorrhage from February 2013 to February 2014 in our hospital were randomly divided into observation group and control group, all in 35 cases. The observation group was treated with Zhuyu Huoxue Decoction combined with urokinase, and the control group Group treated with urokinase, the two groups were compared. Results: The total effective rate of the observation group treated with Zhuyu Huoxue Decoction combined with urokinase was 91.43%, which was significantly higher than that of the control group treated with urokinase (65.71%). There was significant difference between the two groups (P <0.05). Conclusion: Zhuyu Huoxue Decoction combined with urokinase in the treatment of diabetic vitreous hemorrhage has many advantages and is of great value in clinical application in solving the etiological factor.